Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fast Track Strategy in Complicated Pediatric Appendicitis
NCT05761080Phase 4Recruiting
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Apr 2021
- Primary completion
- Jun 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amoxicillin + clavulanate in appendicitis (2 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: Adverse events at 30 days. Started Apr 2021; status: recruiting.
02
Drugs
amoxicillin + clavulanate
03
Conditions
appendicitis
Beyond the preview
Go deeper on NCT05761080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05761080.